Sygnature Discovery Limited, the UK's largest independent provider of integrated drug discovery resources and expertise, has announced the expansion of its DMPK team with the appointment of Ed Browne as Associate Director of Drug Metabolism and Pharmacokinetics (DMPK).

Ed is an experienced drug discovery scientist who brings a thorough understanding of developing and prosecuting a lead optimisation strategy, having worked at GSK, Singapore for the last ten years as head of the DMPK.